About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Osteoarthritis Treatment Market Size, Top Share, Demand, Forecast to 2030
Osteoarthritis Treatment Market

Osteoarthritis Treatment Market Size, Share & Trends Analysis Report By Drugs (Non-steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Hyaluronic Acid Injection, Other Drugs), By Anatomy (Ankle Osteoarthritis, Hip Osteoarthritis, Knee Osteoarthritis, Shoulder Osteoarthritis, Other Anatomies) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Report Code: SRHI2868DR
Author : Debashree Bora
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Osteoarthritis Treatment Market Introduction
    2. By Drugs
      1. Introduction
        1. Drugs By Value
      2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        1. By Value
      3. Corticosteroids
        1. By Value
      4. Hyaluronic Acid Injection
        1. By Value
      5. Other Drugs
        1. By Value
    3. By Anatomy
      1. Introduction
        1. Anatomy By Value
      2. Ankle Osteoarthritis
        1. By Value
      3. Hip Osteoarthritis
        1. By Value
      4. Knee Osteoarthritis
        1. By Value
      5. Shoulder Osteoarthritis
        1. By Value
      6. Other Anatomies
        1. By Value
    1. Introduction
    2. By Drugs
      1. Introduction
        1. Drugs By Value
      2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        1. By Value
      3. Corticosteroids
        1. By Value
      4. Hyaluronic Acid Injection
        1. By Value
      5. Other Drugs
        1. By Value
    3. By Anatomy
      1. Introduction
        1. Anatomy By Value
      2. Ankle Osteoarthritis
        1. By Value
      3. Hip Osteoarthritis
        1. By Value
      4. Knee Osteoarthritis
        1. By Value
      5. Shoulder Osteoarthritis
        1. By Value
      6. Other Anatomies
        1. By Value
    4. U.S.
      1. By Drugs
        1. Introduction
          1. Drugs By Value
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
          1. By Value
        3. Corticosteroids
          1. By Value
        4. Hyaluronic Acid Injection
          1. By Value
        5. Other Drugs
          1. By Value
      2. By Anatomy
        1. Introduction
          1. Anatomy By Value
        2. Ankle Osteoarthritis
          1. By Value
        3. Hip Osteoarthritis
          1. By Value
        4. Knee Osteoarthritis
          1. By Value
        5. Shoulder Osteoarthritis
          1. By Value
        6. Other Anatomies
          1. By Value
    5. Canada
    1. Introduction
    2. By Drugs
      1. Introduction
        1. Drugs By Value
      2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        1. By Value
      3. Corticosteroids
        1. By Value
      4. Hyaluronic Acid Injection
        1. By Value
      5. Other Drugs
        1. By Value
    3. By Anatomy
      1. Introduction
        1. Anatomy By Value
      2. Ankle Osteoarthritis
        1. By Value
      3. Hip Osteoarthritis
        1. By Value
      4. Knee Osteoarthritis
        1. By Value
      5. Shoulder Osteoarthritis
        1. By Value
      6. Other Anatomies
        1. By Value
    4. U.K.
      1. By Drugs
        1. Introduction
          1. Drugs By Value
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
          1. By Value
        3. Corticosteroids
          1. By Value
        4. Hyaluronic Acid Injection
          1. By Value
        5. Other Drugs
          1. By Value
      2. By Anatomy
        1. Introduction
          1. Anatomy By Value
        2. Ankle Osteoarthritis
          1. By Value
        3. Hip Osteoarthritis
          1. By Value
        4. Knee Osteoarthritis
          1. By Value
        5. Shoulder Osteoarthritis
          1. By Value
        6. Other Anatomies
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Drugs
      1. Introduction
        1. Drugs By Value
      2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        1. By Value
      3. Corticosteroids
        1. By Value
      4. Hyaluronic Acid Injection
        1. By Value
      5. Other Drugs
        1. By Value
    3. By Anatomy
      1. Introduction
        1. Anatomy By Value
      2. Ankle Osteoarthritis
        1. By Value
      3. Hip Osteoarthritis
        1. By Value
      4. Knee Osteoarthritis
        1. By Value
      5. Shoulder Osteoarthritis
        1. By Value
      6. Other Anatomies
        1. By Value
    4. China
      1. By Drugs
        1. Introduction
          1. Drugs By Value
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
          1. By Value
        3. Corticosteroids
          1. By Value
        4. Hyaluronic Acid Injection
          1. By Value
        5. Other Drugs
          1. By Value
      2. By Anatomy
        1. Introduction
          1. Anatomy By Value
        2. Ankle Osteoarthritis
          1. By Value
        3. Hip Osteoarthritis
          1. By Value
        4. Knee Osteoarthritis
          1. By Value
        5. Shoulder Osteoarthritis
          1. By Value
        6. Other Anatomies
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Taiwan
    10. South East Asia
    11. Rest of Asia-Pacific
    1. Introduction
    2. By Drugs
      1. Introduction
        1. Drugs By Value
      2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        1. By Value
      3. Corticosteroids
        1. By Value
      4. Hyaluronic Acid Injection
        1. By Value
      5. Other Drugs
        1. By Value
    3. By Anatomy
      1. Introduction
        1. Anatomy By Value
      2. Ankle Osteoarthritis
        1. By Value
      3. Hip Osteoarthritis
        1. By Value
      4. Knee Osteoarthritis
        1. By Value
      5. Shoulder Osteoarthritis
        1. By Value
      6. Other Anatomies
        1. By Value
    4. UAE
      1. By Drugs
        1. Introduction
          1. Drugs By Value
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
          1. By Value
        3. Corticosteroids
          1. By Value
        4. Hyaluronic Acid Injection
          1. By Value
        5. Other Drugs
          1. By Value
      2. By Anatomy
        1. Introduction
          1. Anatomy By Value
        2. Ankle Osteoarthritis
          1. By Value
        3. Hip Osteoarthritis
          1. By Value
        4. Knee Osteoarthritis
          1. By Value
        5. Shoulder Osteoarthritis
          1. By Value
        6. Other Anatomies
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Drugs
      1. Introduction
        1. Drugs By Value
      2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        1. By Value
      3. Corticosteroids
        1. By Value
      4. Hyaluronic Acid Injection
        1. By Value
      5. Other Drugs
        1. By Value
    3. By Anatomy
      1. Introduction
        1. Anatomy By Value
      2. Ankle Osteoarthritis
        1. By Value
      3. Hip Osteoarthritis
        1. By Value
      4. Knee Osteoarthritis
        1. By Value
      5. Shoulder Osteoarthritis
        1. By Value
      6. Other Anatomies
        1. By Value
    4. Brazil
      1. By Drugs
        1. Introduction
          1. Drugs By Value
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
          1. By Value
        3. Corticosteroids
          1. By Value
        4. Hyaluronic Acid Injection
          1. By Value
        5. Other Drugs
          1. By Value
      2. By Anatomy
        1. Introduction
          1. Anatomy By Value
        2. Ankle Osteoarthritis
          1. By Value
        3. Hip Osteoarthritis
          1. By Value
        4. Knee Osteoarthritis
          1. By Value
        5. Shoulder Osteoarthritis
          1. By Value
        6. Other Anatomies
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Osteoarthritis Treatment Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Bayer AG
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. OrthogenRx
    3. Abbott Laboratories
    4. GlaxoSmithKline plc
    5. Sanofi SA
    6. Pfizer Inc.
    7. Zimmer Biomet
    8. Anika Therapeutics Inc.
    9. Mylan (Viatris)
    10. Novartis AG
    11. Assertio Holdings Inc.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The Global Tendonitis Treatment Market was valued at USD 193.03 billion in 2021 and is predicted to reach at USD 257.87 billion by 2030, increasing at a CAGR of 3.27% from 2022 to 2030. When the tendon, which is a flexible but inelastic cord of tiss
Buy Now
Global Report
Global Uveitis Treatment Market Size The global uveitis treatment market size was valued at USD 2.28 billion in 2024 and is expected to grow from USD 2.49 billion in 2025 to reach USD 4.88 billion by 2033, growing at a CAGR of 8.8% du
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.